药物反应与中国儿科患者的NR3C1和FAAH多态性有关
Hongli Wang1, Chu Li2, Qian Li3
1Department of Paediatric, Affiliated Hospital of Chengdu University, Chengdu, 610081, China.
Italian journal of pediatrics
|February 7, 2025
概括
NR3C1的遗传变异可能会影响儿童对抗发作药物 (ASM) 的反应. 这项研究发现,特定的NR3C1多态性与儿科患者更好的药物反应有关.
科学领域:
- 遗传学和神经学 遗传学和神经学
- 药物基因组学 药物基因组学
背景情况:
- 儿童是一种普遍的神经系统疾病,其特点是经常性发作,严重影响儿童的发育.
- 儿科的病因复杂,需要对影响治疗结果的因素进行研究.
研究的目的:
- 研究特定遗传多态 (NR3C1 rs41423247和FAAH rs324420) 与儿童对抗药物 (ASM) 的反应之间的关联.
- 探索这些多态性和药物诱导的肝功能障碍之间的关系.
主要方法:
- 在105名儿科患者中使用聚合酶链反应对NR3C1 rs41423247和FAAH rs324420进行基因定型.
- 根据ASM治疗疗效和肝功能测试 (LFTs) 将患者分为良好和不良反应组.
- 统计分析包括哈迪-韦恩伯格平衡和后勤回归来确定相关性.
主要成果:
- NR3C1 rs41423247多态,特别是CG基因型和C等位基因,与小儿中对ASM的良好反应有显著的关联.
- 在FAAH rs324420多态和ASM反应之间没有发现显著的关联.
- 无论是NR3C1还是FAAH多态都与接受药物治疗的患者的肝功能障碍无关.
结论:
- NR3C1 rs41423247多态可能在预测儿童药物反应方面发挥作用.
- 需要进一步的研究来阐明NR3C1如何影响小儿的ASM疗效的确切机制.
更多相关视频
08:07Simultaneous Detection of c-Fos Activation from Mesolimbic and Mesocortical Dopamine Reward Sites Following Naive Sugar and Fat Ingestion in Rats
Published on: August 24, 2016
9.0K
04:48A High-throughput Calcium-flux Assay to Study NMDA-receptors with Sensitivity to Glycine/D-serine and Glutamate
Published on: July 10, 2018
9.2K
相关概念视频
01:21Factors Affecting Drug Response: Overview
1.8K
When it comes to infants and young children, they are typically administered smaller doses of medication in comparison to adults. This is primarily because their organ functions still need to fully develop, meaning their bodies are not as efficient at metabolizing or eliminating drugs. Additionally, their blood-brain barrier is more permeable than in adults. As a result, high concentrations of drugs can easily penetrate the central nervous system (CNS), potentially leading to neurological...
1.8K
01:20Antiepileptic Drugs: Potassium Channel Activators
140
Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...
Ezogabine has gained approval as an adjunctive treatment...
140